US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Claritev Corporation

40.23

+0.88002.24%

Post-market: 40.230.00000.00%19:30 EDT

Volume:117.65K

Turnover:4.68M

Market Cap:682.58M

PE:-2.37

High:40.29

Open:38.86

Low:36.99

Close:39.35

52wk High:74.07

52wk Low:11.50

Shares:16.97M

Float Shares:5.64M

Volume Ratio:0.94

T/O Rate:2.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-16.9879

EPS(LYR):-17.3000

ROE:-646.34%

ROA:1.19%

PB:-2.32

PE(LYR):-2.33

Loading ...

Overview Company News Filings

Claritev Q2 EPS $(3.49) Beats $(4.21) Estimate, Sales $257.478M Beat $244.813M Estimate

Benzinga Earnings

Claritev Q2 2026 Net Loss Narrows to $59.2 Million; Revenue Rises 6.6% to $257.5 Million

Claritev Corp Q2 Revenue USD 257.478 Million Vs. IBES Estimate USD 244.8 Million

Claritev Corp Q2 Adjusted Ebitda USD 155.8 Million VS. Ibes Estimate USD 147 Million

THOMSON REUTERS

Claritev Corp Q2 Operating Income USD 23.409 Million

THOMSON REUTERS

Press Release: Claritev Corporation Reports Second Quarter 2026 Results

Claritev Corp Expected to Post a Loss of $4.13 a Share - Earnings Preview

Claritev Management to Join Canaccord Genuity Growth Conference Fireside Chat

Multiplan Publishes August 2026 Investor Presentation

Multiplan Q2 Net Profit Rises 61.78% to BRL 427.48 Million; Revenue Climbs 53.44% to BRL 552.39 Million

Multiplan Fecha 2º Trimestre Com Lucro E Receita Acima Do Esperado

Claritev Report Flags Federal Eligibility Issues in Nearly 50% of 2025 no Surprises Act IDR Filings Reviewed

Claritev Sees no Surprises Act IDR Dispute Initiations Top 5.1 Million Through January 2026

Claritev Partners with SAVVI Financial on Benefits Decision Support Tool

Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting

Claritev is Maintained at Buy by Canaccord Genuity

Claritev price target raised to $37 from $32 at Canaccord

Claritev Report Flags 39% Jump in IDR Disputes in H1 2025

Press Release: Claritev Corporation Announces Second Quarter 2026 Earnings Conference Call

Claritev Schedules Q2 Fiscal 2026 Earnings Conference Call

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/CTEV/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTEV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTEV\",,,,,undefined,":{"symbol":"CTEV","market":"US","secType":"STK","nameCN":"Claritev Corporation","latestPrice":40.23,"timestamp":1788379200000,"preClose":39.35,"halted":0,"volume":117649,"hourTrading":{"tag":"盘后","latestPrice":40.23,"preClose":40.23,"latestTime":"19:30 EDT","volume":16713,"amount":672363.83,"timestamp":1788391808059,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.022363405336721612,"floatShares":5637600,"shares":16966900,"eps":-16.987898,"marketStatus":"Not Yet Opened","change":0.88,"latestTime":"09-02 16:00:00 EDT","open":38.86,"high":40.29,"low":36.99,"amount":4681312.181553001,"amplitude":0.083863,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-16.987898,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788422400000},"marketStatusCode":0,"adr":0,"exchange":"NYSE","adjPreClose":39.35,"preHourTrading":{"tag":"盘前","latestPrice":40.42,"preClose":39.35,"latestTime":"08:48 EDT","volume":30,"amount":1212.6000000000001,"timestamp":1788353325038,"change":1.07,"changeRate":0.027192,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":40.23,"preClose":40.23,"latestTime":"19:30 EDT","volume":16713,"amount":672363.83,"timestamp":1788391808059,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.939078,"impliedVol":0.9682,"impliedVolPercentile":0.2948},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTEV\",,,,,undefined,":{"symbol":"CTEV","floatShares":5637600,"roa":"1.19%","roe":"-646.34%","lyrEps":-17.3,"volumeRatio":0.939078,"shares":16966900,"dividePrice":0,"high":40.29,"amplitude":0.083863,"preClose":39.35,"low":36.99,"week52Low":11.5,"pbRate":"-2.32","psRate":"0.69","week52High":74.0699,"institutionHeld":0,"latestPrice":40.23,"eps":-16.987898,"divideRate":0,"volume":117649,"delay":0,"ttmEps":-16.987898,"open":38.86,"prevYearClose":42.75,"prevWeekClose":39.39,"prevMonthClose":39.83,"prevQuarterClose":34.11,"fiveDayClose":37.57,"twentyDayClose":26.13,"sixtyDayClose":27.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTEV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-07","symbol":"CTEV","fiscalQuarterEnding":"2026/06","expectedEps":-4.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786075200000,"reportTimeType":"pre","actualEps":-3.49},{"market":"US","date":"2026-05-07","symbol":"CTEV","fiscalQuarterEnding":"2026/03","expectedEps":-3.81,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-4.41},{"market":"US","date":"2026-02-23","symbol":"CTEV","fiscalQuarterEnding":"2025/12","expectedEps":-3.96,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771822800000,"reportTimeType":"post","actualEps":-4.88},{"market":"US","date":"2025-11-07","symbol":"CTEV","fiscalQuarterEnding":"2025/09","expectedEps":-3.12,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":-4.07},{"market":"US","date":"2025-08-06","symbol":"CTEV","fiscalQuarterEnding":"2025/06","expectedEps":-2.69,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTEV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTEV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":6,"updateTime":1780113600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTEV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTEV","date":"2026-09-01","current":-2.368156,"percent":0.021277,"low":-3.349365,"twenty":-1.783196,"median":-1.318237,"eighty":-0.548511,"high":-0.170756,"avg":-1.224407,"sd":0.652311,"marketCap":675017451},"quantilePoints":[{"date":"2025-03-07","current":-0.191916,"twenty":-0.197447,"median":-0.191916,"eighty":-0.189456,"marketCap":315861468},{"date":"2025-03-14","current":-0.199101,"twenty":-0.197211,"median":-0.192162,"eighty":-0.187507,"marketCap":327686025},{"date":"2025-03-21","current":-0.195853,"twenty":-0.199101,"median":-0.195853,"eighty":-0.189456,"marketCap":322340677},{"date":"2025-03-28","current":-0.216127,"twenty":-0.207643,"median":-0.197969,"eighty":-0.191424,"marketCap":355708607},{"date":"2025-04-04","current":-0.196739,"twenty":-0.206718,"median":-0.199101,"eighty":-0.19231,"marketCap":323798499},{"date":"2025-04-11","current":-0.193589,"twenty":-0.205793,"median":-0.197132,"eighty":-0.19231,"marketCap":318615132},{"date":"2025-04-17","current":-0.199986,"twenty":-0.20599,"median":-0.198855,"eighty":-0.193117,"marketCap":329143847},{"date":"2025-04-25","current":-0.222131,"twenty":-0.206856,"median":-0.199101,"eighty":-0.193195,"marketCap":365589401},{"date":"2025-05-02","current":-0.218489,"twenty":-0.216127,"median":-0.199986,"eighty":-0.193707,"marketCap":359596132},{"date":"2025-05-09","current":-0.29687,"twenty":-0.216324,"median":-0.201167,"eighty":-0.194022,"marketCap":349553357},{"date":"2025-05-16","current":-0.381783,"twenty":-0.220201,"median":-0.203381,"eighty":-0.19477,"marketCap":449534692},{"date":"2025-05-23","current":-0.40691,"twenty":-0.226382,"median":-0.204415,"eighty":-0.195577,"marketCap":479120156},{"date":"2025-05-30","current":-0.501692,"twenty":-0.309019,"median":-0.20658,"eighty":-0.196207,"marketCap":590723101},{"date":"2025-06-06","current":-0.536032,"twenty":-0.373826,"median":-0.209041,"eighty":-0.196739,"marketCap":631156569},{"date":"2025-06-13","current":-0.526958,"twenty":-0.383151,"median":-0.211797,"eighty":-0.196817,"marketCap":620472929},{"date":"2025-06-20","current":-0.563252,"twenty":-0.405877,"median":-0.216127,"eighty":-0.197014,"marketCap":663207489},{"date":"2025-06-27","current":-0.596754,"twenty":-0.523385,"median":-0.218587,"eighty":-0.197388,"marketCap":702654774},{"date":"2025-07-03","current":-0.634165,"twenty":-0.535753,"median":-0.22026,"eighty":-0.197624,"marketCap":746704243},{"date":"2025-07-11","current":-0.664735,"twenty":-0.548455,"median":-0.222131,"eighty":-0.198609,"marketCap":782699891},{"date":"2025-07-18","current":-0.622299,"twenty":-0.561577,"median":-0.261715,"eighty":-0.199101,"marketCap":732733330},{"date":"2025-07-25","current":-0.582376,"twenty":-0.582376,"median":-0.309814,"eighty":-0.199101,"marketCap":685725314},{"date":"2025-08-01","current":-0.556552,"twenty":-0.579166,"median":-0.371453,"eighty":-0.199593,"marketCap":655318032},{"date":"2025-08-08","current":-1.363933,"twenty":-0.582376,"median":-0.381783,"eighty":-0.199986,"marketCap":904797938},{"date":"2025-08-15","current":-1.684055,"twenty":-0.596754,"median":-0.383039,"eighty":-0.199986,"marketCap":1117158561},{"date":"2025-08-22","current":-1.705165,"twenty":-0.609038,"median":-0.401745,"eighty":-0.201167,"marketCap":1131162171},{"date":"2025-08-29","current":-1.770481,"twenty":-0.629977,"median":-0.507694,"eighty":-0.20166,"marketCap":1174490987},{"date":"2025-09-05","current":-1.68033,"twenty":-0.646839,"median":-0.521375,"eighty":-0.202762,"marketCap":1114687336},{"date":"2025-09-12","current":-1.530824,"twenty":-0.692989,"median":-0.533938,"eighty":-0.203588,"marketCap":1015508829},{"date":"2025-09-19","current":-1.375606,"twenty":-1.377791,"median":-0.536381,"eighty":-0.203963,"marketCap":912541110},{"date":"2025-09-26","current":-1.23802,"twenty":-1.366268,"median":-0.537986,"eighty":-0.204336,"marketCap":821270524},{"date":"2025-10-03","current":-1.152588,"twenty":-1.327376,"median":-0.544198,"eighty":-0.20536,"marketCap":764597092},{"date":"2025-10-10","current":-1.44862,"twenty":-1.376798,"median":-0.552224,"eighty":-0.206383,"marketCap":960977125},{"date":"2025-10-17","current":-1.403918,"twenty":-1.382559,"median":-0.554947,"eighty":-0.207131,"marketCap":931322422},{"date":"2025-10-24","current":-1.649535,"twenty":-1.412162,"median":-0.558366,"eighty":-0.208608,"marketCap":1094258540},{"date":"2025-10-31","current":-1.640594,"twenty":-1.453339,"median":-0.563531,"eighty":-0.2091,"marketCap":1088327600},{"date":"2025-11-07","current":-1.538771,"twenty":-1.530228,"median":-0.579166,"eighty":-0.210084,"marketCap":1020780776},{"date":"2025-11-14","current":-2.137789,"twenty":-1.578507,"median":-0.589565,"eighty":-0.211502,"marketCap":730433464},{"date":"2025-11-21","current":-2.187607,"twenty":-1.633144,"median":-0.596754,"eighty":-0.215261,"marketCap":747454878},{"date":"2025-11-28","current":-2.615165,"twenty":-1.640942,"median":-0.60834,"eighty":-0.216127,"marketCap":893541571},{"date":"2025-12-05","current":-1.787134,"twenty":-1.682416,"median":-0.609806,"eighty":-0.216422,"marketCap":610622545},{"date":"2025-12-12","current":-1.88435,"twenty":-1.687561,"median":-0.622299,"eighty":-0.217741,"marketCap":643839090},{"date":"2025-12-19","current":-1.988338,"twenty":-1.707649,"median":-0.634165,"eighty":-0.218607,"marketCap":679369224},{"date":"2025-12-26","current":-2.064756,"twenty":-1.732682,"median":-0.647217,"eighty":-0.219198,"marketCap":705479742},{"date":"2026-01-02","current":-2.067658,"twenty":-1.769935,"median":-0.66969,"eighty":-0.220083,"marketCap":706471281},{"date":"2026-01-09","current":-1.509511,"twenty":-1.763775,"median":-0.697121,"eighty":-0.220595,"marketCap":515765349},{"date":"2026-01-16","current":-1.45389,"twenty":-1.7451,"median":-1.219145,"eighty":-0.221029,"marketCap":496760858},{"date":"2026-01-23","current":-1.453407,"twenty":-1.733974,"median":-1.267698,"eighty":-0.222131,"marketCap":496595602},{"date":"2026-01-30","current":-1.302504,"twenty":-1.730745,"median":-1.277756,"eighty":-0.226264,"marketCap":445035592},{"date":"2026-02-06","current":-1.243013,"twenty":-1.721556,"median":-1.273802,"eighty":-0.226559,"marketCap":424709050},{"date":"2026-02-13","current":-0.966358,"twenty":-1.711374,"median":-1.266581,"eighty":-0.29687,"marketCap":330182367},{"date":"2026-02-20","current":-1.127418,"twenty":-1.706407,"median":-1.25317,"eighty":-0.305635,"marketCap":385212761},{"date":"2026-02-27","current":-0.825068,"twenty":-1.703973,"median":-1.240517,"eighty":-0.309416,"marketCap":234552084},{"date":"2026-03-06","current":-1.03119,"twenty":-1.699304,"median":-1.200271,"eighty":-0.346407,"marketCap":293148724},{"date":"2026-03-13","current":-0.932787,"twenty":-1.693898,"median":-1.145072,"eighty":-0.367715,"marketCap":265174622},{"date":"2026-03-20","current":-0.893193,"twenty":-1.685808,"median":-1.125483,"eighty":-0.371872,"marketCap":253918770},{"date":"2026-03-27","current":-0.928129,"twenty":-1.68187,"median":-1.089934,"eighty":-0.374385,"marketCap":263850404},{"date":"2026-04-02","current":-0.979951,"twenty":-1.680728,"median":-1.034393,"eighty":-0.379047,"marketCap":278582328},{"date":"2026-04-10","current":-1.041088,"twenty":-1.661853,"median":-1.024785,"eighty":-0.382034,"marketCap":295962687},{"date":"2026-04-17","current":-1.144149,"twenty":-1.646486,"median":-1.027988,"eighty":-0.382369,"marketCap":325261006},{"date":"2026-04-24","current":-1.181996,"twenty":-1.643002,"median":-1.041088,"eighty":-0.383151,"marketCap":336020276},{"date":"2026-05-01","current":-1.416649,"twenty":-1.641469,"median":-1.087406,"eighty":-0.393983,"marketCap":402727750},{"date":"2026-05-08","current":-1.436454,"twenty":-1.640942,"median":-1.117261,"eighty":-0.40141,"marketCap":411577020},{"date":"2026-05-15","current":-1.396438,"twenty":-1.641469,"median":-1.133463,"eighty":-0.404844,"marketCap":400111607},{"date":"2026-05-22","current":-1.401198,"twenty":-1.641023,"median":-1.127418,"eighty":-0.463779,"marketCap":401475430},{"date":"2026-05-29","current":-1.461292,"twenty":-1.640924,"median":-1.144149,"eighty":-0.506494,"marketCap":418693697},{"date":"2026-06-05","current":-1.640383,"twenty":-1.640924,"median":-1.167292,"eighty":-0.515428,"marketCap":470007542},{"date":"2026-06-12","current":-1.905748,"twenty":-1.641657,"median":-1.200271,"eighty":-0.520705,"marketCap":546040681},{"date":"2026-06-18","current":-1.770091,"twenty":-1.674171,"median":-1.236729,"eighty":-0.525172,"marketCap":507171722},{"date":"2026-06-26","current":-2.0658,"twenty":-1.686673,"median":-1.248091,"eighty":-0.528354,"marketCap":591899234},{"date":"2026-07-02","current":-1.927763,"twenty":-1.697502,"median":-1.259914,"eighty":-0.533938,"marketCap":552348363},{"date":"2026-07-10","current":-1.957512,"twenty":-1.711374,"median":-1.268816,"eighty":-0.535753,"marketCap":560872258},{"date":"2026-07-17","current":-1.830185,"twenty":-1.733974,"median":-1.276749,"eighty":-0.536032,"marketCap":524389989},{"date":"2026-07-24","current":-1.384538,"twenty":-1.747881,"median":-1.279495,"eighty":-0.53673,"marketCap":396702050},{"date":"2026-07-31","current":-1.402983,"twenty":-1.736755,"median":-1.28934,"eighty":-0.537065,"marketCap":401986864},{"date":"2026-08-07","current":-1.596949,"twenty":-1.731391,"median":-1.299807,"eighty":-0.537819,"marketCap":457562656},{"date":"2026-08-14","current":-2.527372,"twenty":-1.754145,"median":-1.304922,"eighty":-0.539215,"marketCap":715521887},{"date":"2026-08-21","current":-2.040096,"twenty":-1.770169,"median":-1.307495,"eighty":-0.539856,"marketCap":577569539},{"date":"2026-08-28","current":-2.321447,"twenty":-1.778428,"median":-1.313628,"eighty":-0.546752,"marketCap":657222615},{"date":"2026-09-01","current":-2.384302,"twenty":-1.783196,"median":-1.318237,"eighty":-0.548511,"marketCap":675017451}],"updateTime":1788410265021},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTEV\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657619214","title":"Claritev Q2 EPS $(3.49) Beats $(4.21) Estimate, Sales $257.478M Beat $244.813M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657619214","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657619214?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:23","pubTimestamp":1786094607,"startTime":"0","endTime":"0","summary":"Claritev (NYSE:CTEV) reported quarterly losses of $(3.49) per share which beat the analyst consensus estimate of $(4.21) by 17.1 percent. This is a 8.4 percent increase over losses of $(3.81) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61030820/claritev-q2-eps-3-49-beats-4-21-estimate-sales-257-478m-beat-244-813m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616098","title":"Claritev Q2 2026 Net Loss Narrows to $59.2 Million; Revenue Rises 6.6% to $257.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616098","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657616098?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:01","pubTimestamp":1786093290,"startTime":"0","endTime":"0","summary":"Claritev Q2 2026 net loss narrows to $59.2 million; revenue rises 6.6% to $257.5 millionClaritev posted Q2 2026 revenue of USD 257.5 million, up 6.6% from a year earlier.Net loss narrowed to USD 59.2 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDLbdFvrm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657712616","title":"Claritev Corp Q2 Revenue USD 257.478 Million Vs. IBES Estimate USD 244.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657712616","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657712616?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:01","pubTimestamp":1786093260,"startTime":"0","endTime":"0","summary":"BRIEF-Claritev Corp Q2 Revenue USD 257.478 Million Vs. IBES Estimate USD 244.8 MillionAug 07  - Claritev Corp Q2 operating income USD 23.409 million.Q2 pretax profit USD -76.649 millionQ2 net income USD -59.226 millionQ2 adjusted EBITDA USD 155.8 million vs. IBES estimate USD 147 millionoutlook FY revenue USD 1,000-1,020 million vs. IBES estimate USD 993.5 millionoutlook FY adjusted EBITDA USD 610-620 million vs. IBES estimate USD 608.5 millionoutlook FY capex USD 160-170 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nPLXDJGFBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616765","title":"Claritev Corp Q2 Adjusted Ebitda USD 155.8 Million VS. Ibes Estimate USD 147 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657616765?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:00","pubTimestamp":1786093201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nPLXDJGFBH:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616754","title":"Claritev Corp Q2 Operating Income USD 23.409 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657616754?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:00","pubTimestamp":1786093201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nPLXDJGFBH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616237","title":"Press Release: Claritev Corporation Reports Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616237","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657616237?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:00","pubTimestamp":1786093200,"startTime":"0","endTime":"0","summary":"--  Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025. --  Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025. to revenues of $241.6 million for Q2 2025.--  Net loss of $59.2 million for Q2 2026, compared to net loss of $62.6. --  Adjusted EBITDA of $155.8 million for Q2 2026, an increase of 1.1%,compared to Adjusted EBITDA of $154.0 million for Q2 2025.--  Net cash provided by operating activities of $92.7","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGCV","ET","AMZA","TCAF","CTEV","NOBL","BK4144","IXJ","VHT","BK4590","BK4585","BK4588","EMLP","BK4581","TPZ","EIPX","ENFR","BK4167","AMLP","BK4561","BK4550","USAI","TNGY","MDST","MLPA","EIPI","UMI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657854086","title":"Claritev Corp Expected to Post a Loss of $4.13 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657854086","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657854086?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:28","pubTimestamp":1785936485,"startTime":"0","endTime":"0","summary":"Claritev Corp <CTEV.N> expected to post a loss of $4.13 a share - Earnings PreviewClaritev CorpCTEV.N,CTEV.Kis expected to  show a rise in quarterly revenue when it reports  results on August 7 for th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N44221X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656553495","title":"Claritev Management to Join Canaccord Genuity Growth Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2656553495","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656553495?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:02","pubTimestamp":1785844923,"startTime":"0","endTime":"0","summary":"Claritev management to join Canaccord Genuity Growth Conference fireside chatClaritev will participate in the Canaccord Genuity 46th Annual Growth Conference in Boston.Management is scheduled for a fireside chat on Aug. 11, 2026 at 10:00 a.m. ET.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via Business Wire  on August 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL6LMfBW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656300307","title":"Multiplan Publishes August 2026 Investor Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2656300307","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656300307?lang=en_us&edition=fundamental","pubTime":"2026-08-04 05:18","pubTimestamp":1785791913,"startTime":"0","endTime":"0","summary":"Multiplan publishes August 2026 investor presentationMultiplan published its August 2026 investor presentation covering Brazil’s shopping center market, company positioning, 2Q26 operating-financial p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL3wByXj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655138693","title":"Multiplan Q2 Net Profit Rises 61.78% to BRL 427.48 Million; Revenue Climbs 53.44% to BRL 552.39 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655138693","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655138693?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:33","pubTimestamp":1785443597,"startTime":"0","endTime":"0","summary":"Multiplan Q2 net profit rises 61.78% to BRL 427.48 million; revenue climbs 53.44% to BRL 552.39 millionMultiplan posted net income of R$ 427.43 million in Q2 2026, rising from R$ 264.39 million a year earlier.Net revenue climbed to R$ 846.84 million, up from R$ 694.06 million in Q2 2025.Operating profit increased to R$ 664.5 million from R$ 426.55 million, while net financial expense narrowed to R$ 124.99 million from R$ 134.82 million.In the first half, net income totaled R$ 743.6 million, up from R$ 498.48 million; net revenue rose to R$ 1.67 billion from R$ 1.22 billion.Multiplan completed the sale of a 10% stake in BH Shopping for R$ 285 million, cutting its holding to 90%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Multiplan Em","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL89LBK2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655386137","title":"Multiplan Fecha 2º Trimestre Com Lucro E Receita Acima Do Esperado","url":"https://stock-news.laohu8.com/highlight/detail?id=2655386137","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655386137?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:22","pubTimestamp":1785442953,"startTime":"0","endTime":"0","summary":"Multiplan fecha 2 trimestre com lucro e receita acima do esperadoSO PAULO, July 30 (Reuters)-A operadora de shopping centers e empreendimentos imobiliários MultiplanMULT3.SAdivulgou nesta quinta-feira","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nS0N3YG04E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655702058","title":"Claritev Report Flags Federal Eligibility Issues in Nearly 50% of 2025 no Surprises Act IDR Filings Reviewed","url":"https://stock-news.laohu8.com/highlight/detail?id=2655702058","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655702058?lang=en_us&edition=fundamental","pubTime":"2026-07-30 21:01","pubTimestamp":1785416497,"startTime":"0","endTime":"0","summary":"Claritev report flags federal eligibility issues in nearly 50% of 2025 No Surprises Act IDR filings reviewedClaritev’s NSA Trend Report flagged potential federal eligibility issues in nearly 50% of 2025 No Surprises Act IDR filings it reviewed.CMS data showed more than 2.5 million federal IDR disputes filed in 2025, up from 1.5 million in 2024.Total IDR awards topped USD 15 billion, more than tripling year over year, raising cost and administrative pressure across the system.Claritev led non-payer IDR administrators by volume; it managed about 270,000 federal IDR arbitrations at national scale.Clients’ offers were selected in 20% of applicable determinations, versus 12% industrywide, rising to 24% in Q4 versus 15%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL23Sg7x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655817579","title":"Claritev Sees no Surprises Act IDR Dispute Initiations Top 5.1 Million Through January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655817579","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655817579?lang=en_us&edition=fundamental","pubTime":"2026-07-30 06:01","pubTimestamp":1785362464,"startTime":"0","endTime":"0","summary":"Claritev sees No Surprises Act IDR dispute initiations top 5.1 million through January 2026Claritev’s 2026 No Surprises Act trend report flags IDR dispute volume far above expectations, raising payer ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL12kMXv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654000780","title":"Claritev Partners with SAVVI Financial on Benefits Decision Support Tool","url":"https://stock-news.laohu8.com/highlight/detail?id=2654000780","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654000780?lang=en_us&edition=fundamental","pubTime":"2026-07-28 21:03","pubTimestamp":1785243802,"startTime":"0","endTime":"0","summary":"Claritev partners with SAVVI Financial on benefits decision support toolClaritev entered a collaboration with SAVVI Financial to launch Claritev Benefit Decision Support for employer benefits enrollme","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDLD33Ld:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654504582","title":"Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting","url":"https://stock-news.laohu8.com/highlight/detail?id=2654504582","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654504582?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:00","pubTimestamp":1785153600,"startTime":"0","endTime":"0","summary":"– Phase 2a study of CTEV in coronary artery bypass grafting (CABG) is expected to start this quarter – – Progression of CTEV into human study supported by positive preclinical results presented at mul","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/27/3333474/0/en/Humacyte-Announces-FDA-Acceptance-of-IND-for-First-In-Human-Clinical-Study-of-CTEV-for-Coronary-Artery-Bypass-Grafting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AV","CTEV","BK4167","IND","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653427418","title":"Claritev is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2653427418","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653427418?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:30","pubTimestamp":1784633400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTEV/analyst-ratings(END) Dow Jones NewswiresJuly 21, 2026 07:30 ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653715422","title":"Claritev price target raised to $37 from $32 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2653715422","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653715422?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:56","pubTimestamp":1784631396,"startTime":"0","endTime":"0","summary":"Canaccord raised the firm’s price target on Claritev (CTEV) to $37 from $32 and keeps a Buy rating on the shares. The firm updated its model headin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-37-from-32-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-37-from-32-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652425468","title":"Claritev Report Flags 39% Jump in IDR Disputes in H1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2652425468","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652425468?lang=en_us&edition=fundamental","pubTime":"2026-07-17 00:27","pubTimestamp":1784219269,"startTime":"0","endTime":"0","summary":"Claritev report flags 39% jump in IDR disputes in H1 2025Claritev published a 2025 IDR market analysis citing 1,180,000 disputes filed in H1 2025, up 39% versus the prior six months.Providers won abou","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL5qHr6y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651441158","title":"Press Release: Claritev Corporation Announces Second Quarter 2026 Earnings Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2651441158","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651441158?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:05","pubTimestamp":1784203500,"startTime":"0","endTime":"0","summary":"MCLEAN, Va.--(BUSINESS WIRE)--July 16, 2026--Claritev Corporation (\"Claritev\" or the \"Company\") (NYSE: CTEV), a healthcare technology, data and insights company focused on making healthcare more affor","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","TCAF","BK4550","VHT","BK4167","CGCV","NOBL","BK4588","IXJ","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651441984","title":"Claritev Schedules Q2 Fiscal 2026 Earnings Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2651441984","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651441984?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:03","pubTimestamp":1784203387,"startTime":"0","endTime":"0","summary":"Claritev schedules Q2 fiscal 2026 earnings conference callClaritev schedules release of second-quarter fiscal 2026 results before the U.S. market open on Aug. 7, 2026.Earnings conference call set for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL4K3rVf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":97,"code":"91000000","status":"200"}]}}